Chennai, Jan 24: The Federation of Indian Chambers of Commerce and Industry (FICCI) has announced the re-appointment of Dr. GSK Velu as Chairman of the FICCI Tamil Nadu State Council for the year 2025–2026, marking his fifth consecutive year at the helm of the Council.
Dr. Velu is the Chairman and Managing Director of the Trivitron Group of Companies, Neuberg Diagnostics, and Maxivision Super Speciality Eye Hospitals. He is also Director and Shareholder at Kauvery Group of Hospitals, Director and Shareholder at Apollo Dental and Apollo Dialysis, and General & Lending Partner at Stakeboat Capital. In addition, he serves as the Honorary Consul to the Republic of Estonia in India. His continued appointment as Chairman reflects FICCI’s confidence in his ability to provide strategic direction at the intersection of healthcare, manufacturing, investment, and policy.
A distinguished healthcare entrepreneur and industry leader, Dr. Velu brings decades of experience in building affordable, high-quality healthcare and diagnostics solutions. He has played a pivotal role in strengthening India’s healthcare manufacturing and diagnostics ecosystem, while actively promoting innovation, indigenous capability building, and industry–academia collaboration. His leadership has been widely recognised through numerous national and international accolades.
Commenting on his re-appointment, Dr. GSK Velu said, “It is an honour to continue serving as Chairman of the FICCI Tamil Nadu State Council for the fifth consecutive year. Tamil Nadu stands at a critical inflection point—where manufacturing excellence, healthcare innovation, and policy collaboration must converge to create scalable, globally competitive outcomes. I look forward to working closely with industry leaders, policymakers, and stakeholders to strengthen the state’s position as a preferred destination for healthcare manufacturing, med-tech innovation, and knowledge-driven growth.”
During his tenure, Dr. Velu has been instrumental in advancing FICCI Tamil Nadu State Council’s engagement on healthcare manufacturing, diagnostics, med-tech, skilling, and industry–academia collaboration, while ensuring that industry perspectives are effectively represented in policy discourse at both the state and national levels.
His re-appointment for 2025–2026 underscores continuity, stability, and strategic leadership as FICCI Tamil Nadu State Council continues to focus on sustainable growth, innovation-led development, and enhanced global competitiveness for the state’s industry ecosystem.